Grape-seed extract kills laboratory leukemia cells
January 4, 2009
Print This Article
Email this Article
The investigators, who report their findings in the January 1 issue of Clinical Cancer Research, a journal of the American Association for Cancer Research, also teased apart the cell signaling pathway associated with use of grape seed extract that led to cell death, or apoptosis. They found that the extract activates JNK, a protein that regulates the apoptotic pathway.
While grape seed extract has shown activity in a number of laboratory cancer cell lines, including skin, breast, colon, lung, stomach and prostate cancers, no one had tested the extract in hematological cancers nor had the precise mechanism for activity been revealed.
“These results could have implications for the incorporation of agents such as grape seed extract into prevention or treatment of hematological malignancies and possibly other cancers,” said the study’s lead author, Xianglin Shi, Ph.D., professor in the Graduate Center for Toxicology at the University of Kentucky.
“What everyone seeks is an agent that has an effect on cancer cells but leaves normal cells alone, and this shows that grape seed extract fits into this category,” he said.
Shi adds that the research is not far enough along to suggest that people should eat grapes, grape seeds, or grape skin in excess to stave off cancer. “This is very promising research, but it is too early to say this is chemo-protective.” However, “this is a natural compound that appears to have relatively important properties,” Shi said.
Comments
Got something to say?